Herein, we found that overexpression of CSRP2 increased the protein levels of mesenchymal-type markers and decreased the protein levels of proneural-type markers in GBM cells, whereas knockdown of CSRP2 had the opposite effects. The gene discussed is CSRP2; the disease is glioblastoma.